The global market for actigraphy sensors and polysomnography devices is set for significant growth, driven by rising sleep disorder prevalence and advances in technology.
The IndexBox report highlights a projected compound annual growth rate (CAGR) of 6-8% for the actigraphy sensors and polysomnography devices market from 2026 to 2035. This growth is largely attributed to the increasing incidence of sleep disorders like obstructive sleep apnea (OSA) and insomnia, alongside a shift towards home-based monitoring solutions. Currently, polysomnography systems dominate the market, accounting for 55-65% of its value, but actigraphy sensors are gaining traction, particularly in consumer and clinical settings, with an annual growth rate of 8-10%.
Technological advancements, including the integration of artificial intelligence for automated diagnostics, are enhancing the capabilities of polysomnography platforms. This not only reduces the workload for specialists but also expands access to sleep health diagnostics. North America and Europe constitute a significant portion of market revenue, yet the Asia-Pacific region is emerging as the fastest-growing market, driven by increased awareness and infrastructure development.
Despite this optimistic outlook, the market faces challenges such as regulatory hurdles, supply chain issues, and competition from non-clinical devices. The aging population and the growing recognition of sleep health's impact on overall well-being further bolster demand. As the market continues to evolve, the adoption of home sleep apnea testing and advancements in wearable technology will likely play pivotal roles in shaping future growth trajectories.